Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Moghadasi, Abdorreza Naser
NCT06360861: Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis	Completed	1	5	RoW	Allogenic placenta derived mesenchymal stem cells	Tehran University of Medical Sciences	Multiple Sclerosis, Secondary-Progressive Multiple Sclerosis, Mesenchymal Stem Cells	03/24	03/24
Nikbakht, Mohsen
NCT06360861: Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis	Completed	1	5	RoW	Allogenic placenta derived mesenchymal stem cells	Tehran University of Medical Sciences	Multiple Sclerosis, Secondary-Progressive Multiple Sclerosis, Mesenchymal Stem Cells	03/24	03/24
Shokati, Ameneh
NCT06360861: Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis	Completed	1	5	RoW	Allogenic placenta derived mesenchymal stem cells	Tehran University of Medical Sciences	Multiple Sclerosis, Secondary-Progressive Multiple Sclerosis, Mesenchymal Stem Cells	03/24	03/24